IR@PKUHSC  > 北京大学第二临床医学院  > 内分泌科
学科主题临床医学
IL-1B rs1143623 and EEF1A1P11-RPL7P9 rs10783050 polymorphisms affect the glucose-lowing efficacy of metformin in Chinese overweight or obese Type 2 diabetes mellitus patients
Xiao, Di1,2,3; Zhang, Si-Min4; Li, Xi1,2,3; Yin, Ji-Ye1,2,3; Gong, Wei-Jing1,2; Zheng, Yi5; Xu, Xiao-Jing1,2; Lin, Xu6; Ji, Li-Nong4; Liu, Rang-Ru1,2; Tang, Qiang7; Zhang, Wei1,2,3; Zhou, Hong-Hao1,2,3; Han, Xue-Yao4; Liu, Zhao-Qian1,2,3
关键词glucose-lowing efficacy metformin obese overweight pharmacogenomics SNP Type 2 diabetes mellitus
刊名PHARMACOGENOMICS
2015
DOI10.2217/pgs.15.95
16期:14页:1621-1629
收录类别SCI
文章类型Article
WOS标题词Science & Technology
类目[WOS]Pharmacology & Pharmacy
研究领域[WOS]Pharmacology & Pharmacy
关键词[WOS]PREVENTION PROGRAM ; RISK ; ACTIVATION ; OCT1 ; INTERLEUKIN-6 ; INFLAMMATION ; ASSOCIATION ; POPULATION ; PREVALENCE ; VARIANTS
英文摘要

Aim: To investigate the potential genetic effect on metformin efficacy in overweight or obese Chinese Type 2 diabetes mellitus (T2DM) patients. Patients & methods: 768 SNPs in or close to 207 genes were genotyped in 84 patients treated with metformin + glibenclamide/Xiaoke Pill. Significant SNPs were then verified in 107 recent-onset overweight or obese T2DM patients treated with metformin alone. Genotyping was done by Illumina GoldenGate Assay. Results: In the discovery stage, 22 SNPs were nominally significant. IL1B rs1143623 (p = 0.011) and EEF1A1P11-RPL7P9 rs10783050 (p = 0.021) were still significantly associated with the relative change of HbA(1c) in the replication stage. Conclusion:IL1B rs1143623 and EEF1A1P11-RPL7P9 rs10783050 polymorphisms may contribute to metformin′s glucose-lowing efficacy in overweight or obese Chinese T2DM patients.

语种英语
WOS记录号WOS:000363397900008
项目编号2009AA022704 ; 2012AA02A517 ; 2012AA02A518 ; 81173129 ; 81202595 ; 81373490 ; 81273595
资助机构National High-tech R&amp ; D Program of China (863 Program) ; National Natural Science Foundation of China
引用统计
被引频次:3[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/63652
专题北京大学第二临床医学院_内分泌科
作者单位1.Cent S Univ, Xiangya Hosp, Dept Clin Pharmacol, Changsha 410008, Hunan, Peoples R China
2.Huaihua Third Peoples Hosp, Dept Pharm, Huaihua 418000, Peoples R China
3.Cent S Univ, Inst Clin Pharmacol, Hunan Key Lab Pharmacogenet, Changsha 410008, Hunan, Peoples R China
4.Hunan Prov Cooperat Innovat Ctr Mol Target New Dr, Hengyang 421001, Peoples R China
5.Peoples Hosp Peking Univ, Dept Endocrinol, Beijing 100044, Peoples R China
6.Maternal & Child Hlth Hosp Hunan Prov, Changsha 410008, Hunan, Peoples R China
7.Chinese Acad Sci, Shanghai Sch Biol Sci, Inst Nutr Sci, Shanghai 20031, Peoples R China
推荐引用方式
GB/T 7714
Xiao, Di,Zhang, Si-Min,Li, Xi,et al. IL-1B rs1143623 and EEF1A1P11-RPL7P9 rs10783050 polymorphisms affect the glucose-lowing efficacy of metformin in Chinese overweight or obese Type 2 diabetes mellitus patients[J]. PHARMACOGENOMICS,2015,16(14):1621-1629.
APA Xiao, Di.,Zhang, Si-Min.,Li, Xi.,Yin, Ji-Ye.,Gong, Wei-Jing.,...&Liu, Zhao-Qian.(2015).IL-1B rs1143623 and EEF1A1P11-RPL7P9 rs10783050 polymorphisms affect the glucose-lowing efficacy of metformin in Chinese overweight or obese Type 2 diabetes mellitus patients.PHARMACOGENOMICS,16(14),1621-1629.
MLA Xiao, Di,et al."IL-1B rs1143623 and EEF1A1P11-RPL7P9 rs10783050 polymorphisms affect the glucose-lowing efficacy of metformin in Chinese overweight or obese Type 2 diabetes mellitus patients".PHARMACOGENOMICS 16.14(2015):1621-1629.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Xiao, Di]的文章
[Zhang, Si-Min]的文章
[Li, Xi]的文章
百度学术
百度学术中相似的文章
[Xiao, Di]的文章
[Zhang, Si-Min]的文章
[Li, Xi]的文章
必应学术
必应学术中相似的文章
[Xiao, Di]的文章
[Zhang, Si-Min]的文章
[Li, Xi]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。